QIPT
Quipt Home Medical Corp.
NASDAQ · Healthcare · Medical - Devices · US
$3.65
+0.00%Year over year
Reported trailing growth
- Revenue
- +19.3%
- EBITDA
- -9.2%
- EBIT
- —
- EPS
- -58.4%
- Free cash flow
- +17.3%
- Operating cash flow
- +6.5%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +34.6%
- EBITDA
- +27.0%
- EBIT
- —
- Net income
- -58.2%
- EPS
- -56.3%
- Free cash flow
- +13.8%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Dec 1, 2025